Miami, FL – 2025 – The International Society for Stem Cell Application (ISSCA), a division of Global Stem Cells Group (GSCG), is pleased to announce the second edition of its hands-on certification in Regenerative, Functional, and Aesthetic Gynecology, which is expected to bring together physicians from across the globe in Cancún, Mexico, from May 23 to 25, 2025.
This advanced training program is curated by Dr. Jorge Alberto Elías, a respected figure in the field of urogynecology and regenerative medicine, and is designed to offer medical professionals a comprehensive and clinically relevant learning experience that aligns with the evolving demands of women’s health.
Comprehensive Three-Day Structure Focused on Practical Application
The training will span three intensive days, offering participants a carefully planned balance between academic content and real-world application:
- Day 1: Theoretical Sessions
Participants will attend in-depth lectures and engage in discussions exploring the latest developments in regenerative gynecology. Topics will include clinical protocols, biological mechanisms, patient selection, and the integration of regenerative therapies into gynecological and aesthetic practice. - Days 2 & 3: Practical Hands-On Training
Attendees will take part in live demonstrations and perform procedures under the guidance of expert faculty. These sessions will focus on applying protocols in real clinical scenarios, allowing participants to gain confidence in techniques that combine functionality and aesthetics in women’s care.
This format is intended to promote deep learning, peer exchange, and direct observation of the regenerative strategies being taught.
Global Reach Through Hybrid Format
ISSCA recognizes the importance of accessibility and global inclusion in medical education. To this end, the training will be offered in a hybrid format, allowing physicians from different regions to participate in the theoretical component remotely through a secure online platform. Those who attend in person will benefit from the full immersive experience, including access to live patient procedures, faculty interaction, and case-based mentorship.
Expertise You Can Build On
Dr. Jorge Alberto Elías brings more than 30 years of clinical and academic experience to this program. He holds certifications from SOGIBA and the National Academy of Medicine and has been honored by numerous international medical societies. His practice in Buenos Aires, Argentina, Laser Hormonas y Bienestar, specializes in regenerative therapies, hormonal modulation, and aesthetic gynecology.
His leadership in this training is expected to deliver a well-rounded curriculum based on real-world practice, cutting-edge techniques, and evidence-based strategies.
Key Topics Expected to Be Covered:
- Umbilical cord donor-derived stem cells in gynecological therapies
- Exosomes and regenerative medicine applications in women’s health
- Advanced treatment protocols for lichen sclerosus
- Aesthetic gynecology procedures and rejuvenation techniques
- Personalized hormonal modulation and endocrine balance strategies
- Intimate rejuvenation using laser and radiofrequency technologies
- Minimally invasive approaches to urinary incontinence
- Genital cosmetic surgery and aesthetic enhancements
- Sexual wellness recovery through regenerative medicine protocols
These topics are intended to provide physicians with practical tools to expand their services and address a broader range of functional, aesthetic, and emotional aspects related to women’s health.
A Vision for the Future of Women’s Care
“We hope this training will serve as a platform for physicians to explore new approaches in gynecologic care, supported by regenerative science,” said Benito Novas, Founder of ISSCA and CEO of Global Stem Cells Group. “By learning from Dr. Elías, we expect participants will gain clinical knowledge that can enhance their perspective and elevate the level of care they provide.”
Dr. Elías added, “This program is the result of decades of continuous work and research in the area of women’s wellness. We believe that combining functional and aesthetic aspects of gynecology through regenerative strategies may open new doors for physicians and improve patient satisfaction in meaningful ways.”
About the International Society for Stem Cell Application (ISSCA)
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary global network of physicians and scientists committed to the advancement of regenerative medicine and stem cell-based therapies. ISSCA’s mission is to lead in certification, education, research, and training, promoting high standards and best practices in the field. With members in over 35 countries, the organization fosters collaboration and knowledge-sharing to support the safe and effective implementation of cutting-edge cellular treatments in clinical practice.
About Global Stem Cells Group (GSCG)
Global Stem Cells Group (GSCG) is an international consortium dedicated to stem cell research, clinical applications, and physician education. The organization brings together several specialized companies under one umbrella to offer innovative patient treatment protocols, hands-on training programs, and regulatory consulting. GSCG is committed to expanding access to regenerative medicine worldwide and supports physicians through certification programs, conferences, and scientific collaboration.
Global Stem Cells Group is a publicly traded company operating under the symbol RMTG. https://finance.yahoo.com/quote/RMTG/
To learn more about Global Stem Cells Group, Inc.’s companies, visit our website www.stemcellsgroup.com or call +1 305 560 5331.
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Register Now
Seats are limited for this high-demand certification. To reserve your spot or to learn more, please visit: www.issca.com
